Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. PRAXBIND (idarucizumab)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

PRAXBIND (idarucizumab)

Medicine - Posted on Dec 18 2018 - Updated on Jun 12 2019
Active substance (DCI)
  • idarucizumab
history (2)
  • 6/13/18

    PRAXBIND (idarucizumab), dabigatran neutralising agent

    High clinical benefit for emergency neutralisation of the anticoagulant effect of dabigatran and minor clinical improvement,...
    CAV :
    54321
    icône flèche
  • 5/25/16

    PRAXBIND (idarucizumab), antidote for dabigatran

    No clinical benefit demonstrated when compared with current treatment PRAXBIND is a neutralising agent specific to the antic...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • V03AB37
Manufacturer
BOEHRINGER INGELHEIM FRANCE
Presentation

PRAXBIND 2,5 g/50 ml, solution injectable/pour perfusion (code CIS : 63555182) 2 flacon(s) en verre de 50 ml - Code CIP : 34009 550 136 9 3

All our publications
    Blood coagulation and hemostasis disorders Drug therapy

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
4AWW4UGu2V565UtD